Neurology CDMOs

Symphony Pharma Life Sciences Pvt Ltd

India

Symphony Pharma Life Sciences is a CRO and CDMO based in Hyderabad, India, founded in 2008 by research-driven scientists. The company operates a 25,000+ sq. ft. research facility in Genome Valley, providing contract research, custom synthesis, and contract development and manufacturing services. Symphony has executed 40+ NCE intermediate projects for global innovator companies, developed 8 new APIs (including Lacosamide with USFDA-approved DMF), and synthesized 250+ API impurities for global MNCs.

Synergene Active Ingredients Private Limited

India

Synergene Active Ingredients is a fast-growing Indian API manufacturer incorporated in 2006, with 40 years of industrial experience and 800+ employees. The company manufactures 30+ APIs serving 300+ customers in 50+ countries. Synergene operates four manufacturing units in Hyderabad and Visakhapatnam with combined production capacity of 800+ KL (plus 700 KL under installation). The company has CEPs from EDQM, US DMFs, Japanese DMFs, ANVISA CBPF, and WHO GMP certifications. Synergene also produces specialty chemicals for skincare, sun care, and haircare applications.

Syn-Tech Chem & Pharm Co. Ltd

Taiwan

Syn-Tech Chem & Pharm Co. Ltd is a Taiwanese API manufacturer established over 30 years ago, providing good quality APIs to customers worldwide including USA, Japan, Korea, and Europe. The company has passed multiple regulatory audits and holds PMDA, US FDA, KFDA, and TFDA approvals. Syn-Tech is expanding its CDMO capabilities and manufactures APIs such as guanfacine HCl and crotamiton. The company won the 2003 National Biotechnology and Medical Quality Award in Taiwan.

TITAN PHARMAPLUS PVT. LTD

India

Titan Pharmaplus Pvt. Ltd. is an Indian pharmaceutical API manufacturer and CDMO committed to innovation, quality, and sustainability. The company produces a wide range of small molecule APIs including Apixaban, Dapagliflozin, Acyclovir, Dexlansoprazole, and controlled substances, with state-of-the-art cGMP facilities and advanced chemical synthesis capabilities including high-pressure hydrogenation, Grignard reactions, and asymmetric oxidation.

Trifarma S.p.A.

Italy

Trifarma S.p.A. is an international and independent Italian group dedicated to developing, manufacturing, and supplying high-quality Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. The company has R&D laboratories for synthetic organic chemistry process development at lab and pilot scale, with rapid lab-to-industrial scale development. API portfolio covers cardiovascular, anti-infective, nervous system, dermatological/ophthalmic, steroids, and musculoskeletal categories.

Vamsi Labs Ltd

India

Vamsi Labs Ltd. is a major Indian manufacturer of Active Pharmaceutical Ingredients (APIs) based in Solapur, Maharashtra. Founded over 28 years ago, the company operates a USFDA-approved, ISO 9001:2015/ISO 14001:2015/ISO 45001:2018 certified facility. Specializes in anti-asthmatic (respiratory), anti-migraine, and anti-psychotic APIs, with 60% of sales from antiasthma products. Products are manufactured in 3 blocks with 8 dedicated product lines containing 70 reactors (10L to 10,000L). Also offers CRAMS (Custom Research and Manufacturing Services) with capability for reactions from -60C to 280C. Has micronization capability for inhaled products using Malvern Mastersizer 2000. Holds US FDA EIR, CEP certifications for multiple APIs (Formoterol Fumarate, Salmeterol Xinafoate, Tiotropium Bromide, Fluticasone Propionate, etc.), WHO-GMP, and EcoVadis sustainability scorecard.

Vihita Chem (P) Ltd

India

Vihita Chem Private Limited is an Indian API and intermediates manufacturer established in 1990 in Ankleshwar, Gujarat. The company manufactures APIs (Donepezil, Valsartan, Losartan, Atorvastatin, Pinaverium Bromide), API intermediates, fragrance intermediates, specialty chemicals, and customized products. Three manufacturing facilities in Ankleshwar GIDC, with additional land acquired at Dahej and Jhagadia for Units 3 and 4. ISO 9001:2015, ISO 14001:2015, ISO 45001:2018 certified. FEI number 3004562353. R&D recognized by DSIR, Ministry of Science and Technology, Government of India. 200+ employees, 100+ products. Building EU-GMP facility in Unit-2.

Anhui Biochem Pharmaceutical (ABUP) is a Chinese pharmaceutical company manufacturing APIs, intermediates, and finished dosage forms, with a focus on antiviral drugs (AIDS and hepatitis) and Parkinson's disease medications. They also offer customized processing (contract manufacturing) services.

Bionex Pharmaceuticals LLC is a US-based pharmaceutical development CRMO (Contract Research and Manufacturing Organization) specializing in novel topical, transdermal/transmucosal, and implant drug delivery systems. They offer pre-formulation through clinical supply manufacturing, with many R&D projects funded by NIH and NSF grants. Located at the New Jersey Bioscience Center. They have had 3 FDA recalls (1 Class I, 2 Class II).

Cenra Pharma (formerly CCPC, China Chemical & Pharmaceutical Co.) is a Taiwanese pharmaceutical company established in 1952 that develops and manufactures APIs and generic drugs, also providing CMO/CDMO services. The company has FDA and PMDA facility approvals, PIC/S GMP compliance, and offers services from API selection through formulation development and commercial manufacturing. Cenra specializes in high-potency drugs including immunosuppressants and oncology drugs, with dedicated production lines for penicillins, cephalosporins, carbapenems, and immunosuppressants.

Exemed Pharmaceuticals

India

Exemed Pharmaceuticals is an Indian pharmaceutical company established in 2009, with US FDA, EDQM, and EU GMP certified manufacturing facilities in Vadodara and Vapi, Gujarat. The company manufactures APIs including Metformin HCL, Allopurinol, Levetiracetam, and Vildagliptin, and also has a finished formulation manufacturing facility acquired from UCB India.

Fermion, a wholly owned subsidiary of Orion Corporation (Finland), is a CDMO specializing in developing, manufacturing, and marketing small molecule Active Pharmaceutical Ingredients (APIs), including HPAPIs, cytotoxics, steroids, generics, and controlled substances. Together with its parent Orion, it offers integrated contract development and manufacturing services for both drug substances and drug products, covering the full lifecycle from preclinical to commercial scale. FDA-approved since 1979 and EMA-approved since 1971.

FGK Clinical Research

Czechia

FGK Clinical Research is a European full-service contract research organization (CRO) based in Munich, Germany, offering clinical development and consulting services to pharmaceutical, biotechnology, and medical device companies. It specializes in clinical trials across multiple therapeutic areas including oncology, neurology, cardiovascular, and advanced therapy medicinal products (ATMPs).

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

Jubilant HollisterStier CMO

Canada

Jubilant HollisterStier CMO (subsidiary of Jubilant Pharma) specializes in sterile fill-finish, lyophilization, injectables, ophthalmics, otics, topicals, and liquids for pharmaceutical and biopharmaceutical clients. End-to-end services from process development to inspection and packaging. Facilities in Spokane, WA and Montreal, QC. Won AWB Manufacturer of the Year 2024 and Manufacturing Excellence Award 2025. Largest manufacturer by employees in Spokane area. 92% repeat customer rate. FDA registered with 4 FEI numbers, 28 inspections (6 NAI, 18 VAI, 4 OAI -- elevated regulatory risk).

Labcorp (incl. Labcorp Drug Development/Covance)

United States

Labcorp (including Labcorp Drug Development, formerly Covance) is one of the world's largest contract research organizations (CROs). They provide comprehensive drug development services including nonclinical development (toxicology, pharmacology, metabolism), central laboratory services (bioanalytical, biomarkers, genomics, companion diagnostics), and commercialization services. Labcorp supported 76% of all FDA-approved drugs in 2024. They operate across 100+ countries with services spanning from drug discovery to post-approval. While they offer CMC consulting services, their core business is contract research, not contract drug manufacturing.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Northeast Pharmaceutical Group (NEPG) is a large-scale comprehensive pharmaceutical enterprise in Shenyang, China, under Fangda Group. The company operates three major business segments: chemical synthetic API and bio-fermentation API, western medicinal preparations and micro-ecological preparations, and medical business distribution. NEPG is China's first Vitamin C producer and the inventor of the two-step fermentation technology for VC production, with the world's largest Piracetam production capacity.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).

Parexel International (MA) Corporation

Argentina

Parexel is a global contract research organization (CRO) providing clinical trial management, regulatory consulting, and biopharmaceutical development services. With over 24,000 professionals and 50+ clinical sites across five continents, the company offers Phase I-IV clinical trial services, CMC regulatory strategy, and real-world evidence generation. Parexel is primarily a CRO, not a drug manufacturer.

Piramal Pharma Solutions (PPS) is a global CDMO under Piramal Pharma Limited, offering end-to-end development and manufacturing solutions across the drug lifecycle. Operates through a globally integrated network of 17 development and manufacturing facilities across North America, Europe, and Asia, with distribution in 100+ countries. Services include drug discovery, process/pharmaceutical development, clinical trial supplies, and commercial supply of APIs and finished dosage forms. Specialized in highly potent APIs, antibody-drug conjugations, sterile fill/finish, and peptide products. Multiple CDMO Leadership Award winner.

Prime Health Ltd. is a contract manufacturer for natural health products, nutritional supplements, and pharmaceutical products. Based in Maple Ridge, British Columbia, Canada (not UK as listed), they have a modern facility with advanced equipment. Job postings mention production workers for tablet coating, quality control technicians, R&D technicians, encapsulation roles, and formulation technicians. FDA-registered with FEI 3021784212 with 1 FDA inspection (VAI in 2022). Also listed on PharmaSource as a contract manufacturer and appearing at CPHI Frankfurt. The UK-based Prime Health referenced by Apposite Capital appears to be a different entity (www.prime-health.co.uk).

SEDICO Pharmaceutical Company is an Egypt-based pharmaceutical manufacturer and API producer, providing contract manufacturing (CMO/CDMO) services. The company manufactures a broad range of pharmaceutical products including oral solids, injectables, and various dosage forms. SEDICO has recently entered oncology drug production through a partnership with Sandoz Global to localize oncology pharmaceutical products in Egypt.

DUPLICATE ENTRY: This is the same company as Standard Chem. & Pharm. Co. Ltd (companyId: 6a650983). See primary entry for full profile. Standard Chem. & Pharm. Co., Ltd. (SCP) is a Taiwanese CDMO established in 1967.

Zambon is an Italian multinational healthcare group founded in 1906 with EUR 899 million in revenues and 2,768 employees. The group operates as both a pharmaceutical company (Zambon Pharma) and a CDMO, offering contract development and manufacturing services ranging from development through commercial production. Manufacturing plants in Vicenza (Italy), Cadempino (Switzerland), Haikou (China), and Barueri (Brazil) supply 87 countries. Also includes Zach System (API custom synthesis) as its chemical division.

I Peace Inc. is a Palo Alto, California-based biotech CDMO specializing in cGMP manufacturing of iPSC (induced pluripotent stem cells) and iPSC-derived cell products for cell and gene therapy development. The company provides custom GMP cell manufacturing, process development, cell banking (MCB/WCB), gene editing, differentiation services, and regulatory support compliant with FDA, PMDA, and EudraLex standards. I Peace has manufactured 100+ GMP iPS cell lines and tripled its CDMO facility capacity.

Lundbeck Pharmaceuticals Italy SpA

Italy

Lundbeck Pharmaceuticals Italy SpA is an Italian API manufacturer with 80 years of industry experience, producing Active Pharmaceutical Ingredients including Metoclopramide Hydrochloride. Part of the Lundbeck Group (Denmark), they operate multiple FDA-registered facilities with extensive inspection history. While primarily a proprietary pharma manufacturer (Lundbeck is known for CNS drugs), their Italian operation manufactures APIs and has FDA-approved products across injectable and oral dosage forms. They also have clinical trial activity in CNS/Neurology and Immunology.

SCI Pharmtech Inc. is a Taiwan-based API manufacturer originally founded by Switzerland-based Siegfried Ltd. in 1987, now publicly listed on the Taiwan Stock Exchange. The company specializes in APIs, advanced intermediates, and custom products with US FDA and EDQM inspected, ISO-certified facilities. SCI Pharmtech focuses on rapid development and cost-effective production.

Corning Incorporated (Life Sciences & Pharmaceutical Technologies)

India

Corning Incorporated's Pharmaceutical Technologies division manufactures advanced glass packaging solutions for the pharmaceutical industry, most notably Valor Glass vials and containers designed for drug storage and delivery. The company is a materials science and glass technology company, not a drug manufacturer or CDMO.

DWK Life Sciences

Germany

DWK Life Sciences is a German company that manufactures laboratory glassware, tubular glass container closure systems (CCS), and packaging solutions for the pharmaceutical and life sciences industries. Through its subsidiary Mueller + Mueller, it provides pharmaceutical packaging solutions. It is a glass and labware supplier, not a drug manufacturer.

EMA Pharmaceuticals (Ema Pharma)

France

EMA Pharmaceuticals (Ema Pharma) is a French manufacturer of overseals (crimping capsules) for injectable pharmaceutical applications. The company specializes in sealing solutions for vials used in pharmaceutical injectable products, manufactured in a GMP-compliant facility. Note: The FDA regulatory data (90 approved products, 184 recalls) appears to be associated with a different entity sharing the FEI registrations, not the French crimp cap manufacturer.

SteriMax Inc.

Canada

SteriMax Inc. is a family-owned Canadian specialty pharmaceutical company based in Oakville, Ontario. They develop, source, manufacture, market, and distribute essential hospital and retail pharmacy products to the Canadian healthcare market. Their portfolio includes generic and branded products across sterile injectables, oral solids, and other essential products. SteriMax has a Health Canada-approved QC lab and their products are manufactured in Health Canada, FDA, or EMEA approved facilities. While they have some internal pharmaceutical manufacturing capabilities (their website mentions production and manufacturing), their primary model appears to be sourcing, marketing, and distributing pharmaceutical products in Canada rather than offering contract manufacturing services to third parties. They are not positioned as a CDMO/CMO.